Due to the potential of EMT to foster escape to ACACA‐targeted therapies, we highly advise that careful attention be paid to the adverse effects mentioned above, as well as to the therapeutic agents derived from them, particularly in the case of MAPK‐related prostate cancers. This evidence concerns the gene ACACA and Familial prostate cancer.